ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistan...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Klinicist |
Subjects: | |
Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/125 |
_version_ | 1797855628956270592 |
---|---|
author | S. Yu. Martsevich N. P. Kutishenko M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya |
author_facet | S. Yu. Martsevich N. P. Kutishenko M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya |
author_sort | S. Yu. Martsevich |
collection | DOAJ |
description | Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented. |
first_indexed | 2024-04-09T20:27:00Z |
format | Article |
id | doaj.art-c0e249fe7cb94a449acf43df739a0a30 |
institution | Directory Open Access Journal |
issn | 1818-8338 |
language | Russian |
last_indexed | 2024-04-09T20:27:00Z |
publishDate | 2014-07-01 |
publisher | ABV-press |
record_format | Article |
series | Klinicist |
spelling | doaj.art-c0e249fe7cb94a449acf43df739a0a302023-03-30T20:14:08ZrusABV-pressKlinicist1818-83382014-07-0152727910.17650/1818-8338-2011-2-72-79140ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCES. Yu. Martsevich0N. P. Kutishenko1M. L. Ginzburg2A. M. Malysheva3Yu. N. Polyanskaya4State Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia I.M. Sechenov First Moscow State Medical UniversityState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaLyubertsy District Hospital № 2, Moscow RegionState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaEvidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented.https://klinitsist.abvpress.ru/Klin/article/view/125antiplatelet agentsaspirinclopidogrelmyocardial infarctiondrug resistanceproton pump inhibitors |
spellingShingle | S. Yu. Martsevich N. P. Kutishenko M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE Klinicist antiplatelet agents aspirin clopidogrel myocardial infarction drug resistance proton pump inhibitors |
title | ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE |
title_full | ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE |
title_fullStr | ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE |
title_full_unstemmed | ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE |
title_short | ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE |
title_sort | antiplatelet therapy in patients with high risk of thrombotic events the problem of efficiency safety and compliance |
topic | antiplatelet agents aspirin clopidogrel myocardial infarction drug resistance proton pump inhibitors |
url | https://klinitsist.abvpress.ru/Klin/article/view/125 |
work_keys_str_mv | AT syumartsevich antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance AT npkutishenko antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance AT mlginzburg antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance AT ammalysheva antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance AT yunpolyanskaya antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance |